Stonepine Capital Management, LLC and related reporting persons filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 579,912 shares of CalciMedica, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: 579,912 shares of CalciMedica, Inc. common stock reported by each of the four reporting persons.
  • Ownership percentage: 8.1% of the class, calculated based on 6,895,149 shares outstanding as of November 5, 2026.
  • Holdings composition: 278,680 shares of common stock plus warrants to acquire 301,232 shares of common stock, subject to a 9.99% beneficial ownership limitation.
  • Voting and dispositive power: All 579,912 shares held with shared voting power and shared dispositive power; sole voting and sole dispositive power are each reported as 0.
  • Reporting persons: Stonepine Capital Management, LLC; Stonepine Capital, L.P.; Stonepine GP, LLC; and Jon M. Plexico, filing jointly but not as members of a group.
  • Triggering event date: September 30, 2026, as stated in the filing.

Stonepine Capital's Amended 13G Filing on CalciMedica Ownership

According to the amended Schedule 13G (Amendment No. 1), Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico each reported beneficial ownership of 579,912 shares of CalciMedica, Inc. common stock. The filing states that the securities consist of 278,680 shares of common stock and warrants to acquire an additional 301,232 shares, with the warrant exercise subject to a 9.99% beneficial ownership limitation. The percentage of class, reported as 8.1%, is calculated based on 6,895,149 shares of common stock outstanding as of November 5, 2026, as reported in CalciMedica's Form 10-Q filed on November 10, 2026.

The filing describes the organizational relationships among the reporting persons: Stonepine Capital Management, LLC serves as investment adviser, and Stonepine GP, LLC serves as general partner, both of Stonepine Capital, L.P. Jon M. Plexico is identified as the control person of Stonepine Capital Management, LLC and Stonepine GP, LLC. The filing states the reporting persons are filing jointly "but not as members of a group," and each disclaims membership in a group. The filing also states that each reporting person "disclaims beneficial ownership of shares of Common Stock except to the extent of that person's pecuniary interest therein."

All four reporting persons report zero sole voting power and zero sole dispositive power. Shared voting power and shared dispositive power are each reported as 579,912 shares for every reporting person. The filing was signed by Jon M. Plexico in his capacity as Managing Member of Stonepine Capital Management, LLC and is dated November 13 of the filing year. CalciMedica, Inc. is a Delaware-incorporated issuer with principal offices at 505 Coast Boulevard South, Suite 300-9, La Jolla, CA 92037. The reporting persons are based at 2900 NW Clearwater Drive, Suite 100-11, Bend, OR 97703.

What Was Disclosed

Stonepine Capital Management, LLC and three affiliated reporting persons filed an amended Schedule 13G disclosing aggregate beneficial ownership of 579,912 shares, or 8.1%, of CalciMedica, Inc. common stock as of September 30, 2026, comprised of direct shares and warrant-covered shares.